BR0317196A - Composição farmacêutica oleosa e uso de lipìdios peroxidados - Google Patents

Composição farmacêutica oleosa e uso de lipìdios peroxidados

Info

Publication number
BR0317196A
BR0317196A BR0317196-5A BR0317196A BR0317196A BR 0317196 A BR0317196 A BR 0317196A BR 0317196 A BR0317196 A BR 0317196A BR 0317196 A BR0317196 A BR 0317196A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
peroxidized lipids
oily pharmaceutical
oily
peroxidized
Prior art date
Application number
BR0317196-5A
Other languages
English (en)
Other versions
BRPI0317196B1 (pt
Inventor
Stephane Desjonqueres
Original Assignee
Carilene Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carilene Lab filed Critical Carilene Lab
Publication of BR0317196A publication Critical patent/BR0317196A/pt
Publication of BRPI0317196B1 publication Critical patent/BRPI0317196B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286—Carthamus (distaff thistle)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Edible Oils And Fats (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA OLEOSA E USO DE LIPìDIOS PEROXIDADOS" A presente invenção trata de uma composição farmacêutica oleosa à base de lipídios peroxidados e de sílica caracterizada pelo fato de conter, a título de constituintes essenciais, lipídios peroxidados que apresentam uma taxa de peroxidação compreendida entre 5 e 600 miliequivalentes por quilo e sílica dispersada nos referidos lipídios peroxidados em uma concentração superior ou igual a 0,5 % em peso e inferior a 4 % em peso em relação ao peso da referida composição. Nesta composição, os lipídios peroxidados são obtidos de preferência por peroxidação de um óleo vegetal natural e a sílica é de preferência a sílica coloidal. A presente invenção trata ainda do uso da composição para a fabricação de uma composição farmacêutica destinada ao tratamento da xerostomia.
BRPI0317196A 2002-12-23 2003-12-22 composição farmacêutica oleosa e uso de lipídios peroxidados BRPI0317196B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0216517A FR2848852B1 (fr) 2002-12-23 2002-12-23 Composition huileuse a base de lipides peroxydes utilisable dans le traitement de la xerostomie
PCT/FR2003/003861 WO2004058138A2 (fr) 2002-12-23 2003-12-22 Composition huileuse a base de lipides peroxydes utilisable dans le traitement de la xerostomie

Publications (2)

Publication Number Publication Date
BR0317196A true BR0317196A (pt) 2005-11-01
BRPI0317196B1 BRPI0317196B1 (pt) 2016-09-27

Family

ID=32406398

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0317196A BRPI0317196B1 (pt) 2002-12-23 2003-12-22 composição farmacêutica oleosa e uso de lipídios peroxidados

Country Status (10)

Country Link
US (1) US8367650B2 (pt)
EP (1) EP1575670B1 (pt)
JP (1) JP4712393B2 (pt)
AT (1) ATE482746T1 (pt)
AU (1) AU2003303330A1 (pt)
BR (1) BRPI0317196B1 (pt)
DE (1) DE60334403D1 (pt)
ES (1) ES2358073T3 (pt)
FR (1) FR2848852B1 (pt)
WO (1) WO2004058138A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1902753A1 (de) * 2006-09-19 2008-03-26 Thomas Dr. Tenspolde Spülung für den Mundinnenraum
US9597278B2 (en) 2008-11-13 2017-03-21 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort
US9884082B2 (en) 2008-11-13 2018-02-06 David A. Hamlin Compositions and methods for alleviating hyposalivation and for providing oral comfort
EP2367526A1 (en) * 2008-11-13 2011-09-28 VDF Futureceuticals, Inc. Compositions and methods for alleviating hyposalivation and for providing oral comfort
MX338801B (es) 2011-05-16 2016-05-02 Colgate Palmolive Co Composiciones de cuidado oral.
CN104208564A (zh) * 2014-09-25 2014-12-17 周红玲 一种治疗反复性口腔溃疡的中药
FR3053252B1 (fr) * 2016-06-29 2020-04-24 Laboratoires Carilene Produit, ou agent actif, ou composition pour le soin des seins en periode pre-mensuelle ou menstruelle ou pour le soin de la symptomatologie des mastodynies
EP3727336A1 (en) 2017-12-20 2020-10-28 3M Innovative Properties Company Oral compositions and methods of use
US20220003741A1 (en) 2018-11-16 2022-01-06 Decimadx, Llc Oral wash for oral fluid collection and analysis and methods of use thereof
CA3194143A1 (en) 2020-09-29 2022-04-07 Decimadx, Llc Compositions, kits and methods for collecting analyte in a saliva sample

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2591110B1 (fr) * 1985-12-06 1989-02-24 Desjonqueres Stephane Composition medicamenteuse a base d'huile naturelle d'origine vegetale destinee a etre utilisee pour le traitement des hemorroides.
FR2649011A1 (fr) * 1989-07-03 1991-01-04 Carilene Laboratoires Produit medicamenteux pour la revascularisation des tissus
FR2705568B1 (fr) * 1993-05-27 1995-08-18 Carilene Laboratoires Utilisation de lipides peroxydés pour la préparation d'une composition pharmaceutique destinées au traitement par application locale des télangiectasies.
FR2797584B1 (fr) * 1999-08-16 2008-07-25 Stephane Desjonqueres Utilisation de lipides peroxydes dans le traitement ou la prevention des plaies et inflammations des muqueuses de la cavite buccale

Also Published As

Publication number Publication date
US20060078620A1 (en) 2006-04-13
AU2003303330A8 (en) 2004-07-22
FR2848852A1 (fr) 2004-06-25
ATE482746T1 (de) 2010-10-15
WO2004058138A3 (fr) 2004-09-30
JP4712393B2 (ja) 2011-06-29
DE60334403D1 (de) 2010-11-11
US8367650B2 (en) 2013-02-05
ES2358073T3 (es) 2011-05-05
WO2004058138A2 (fr) 2004-07-15
FR2848852B1 (fr) 2007-03-16
JP2006513199A (ja) 2006-04-20
AU2003303330A1 (en) 2004-07-22
EP1575670B1 (fr) 2010-09-29
BRPI0317196B1 (pt) 2016-09-27
EP1575670A2 (fr) 2005-09-21

Similar Documents

Publication Publication Date Title
CY1107583T1 (el) Γελη πepιλαμβανουσα τουλαχιστον ενα ρετινοειδες και βενζοϋλο-υπepοξειδιο
EP2261200A3 (en) Modified forms of pharmacacologically active agents and uses therefor
BR0317196A (pt) Composição farmacêutica oleosa e uso de lipìdios peroxidados
AU2001253752A1 (en) Method and apparatus for predictively quantizing voiced speech
BR0205612A (pt) Componentes e catalisadores para a (co) polimerização de olefinas
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
AU2001282399A1 (en) Resorcinol derivatives
CY2009017I1 (el) Μεθοδος για την παρασκευη 10, 11-διυδρο-10-υδροξυ-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου και 10,11-διυδρο-10-οξο-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου
BR0100541A (pt) Suplemento de alimentação pró-energético baseado em nadh, octocosonol e vitamina e
BR0314058A (pt) Composições para cuidados pessoais a base de álcool ramificado
BR0207335A (pt) Sistema polimerizável
BR9903890A (pt) Veìculo revestido
ATE342004T1 (de) Operationswerkzeug
NO20034524D0 (no) 5-leddete heterocykler, fremstilling og anvendelse derav som MAO inhibitorer og lipidperoksidasjonsinhibitorer, fremstilling derav oganvendelse derav sommedikamenter
BR9908541A (pt) Alternador de veìculo
MX9909797A (es) Composiciones para el cuidado personal que comprenden un copolimero adhesivo.
ATE305796T1 (de) Präparationen von vitamin e in kombination mit afamin
ATE318834T1 (de) Lipide mit aminoxygruppe
DE60034770D1 (de) Stabile fumagillin-formulierung
BR9901381A (pt) Composições para a cura de polìmero
NO984386D0 (no) Blandinger omfattende en HIV-protease-inhibitor sÕ som VX 478 og en vannl°selig vitamin E-forbindelse sÕ som vitamin E-TPG'er
WO2001013675A3 (de) Beleuchtete Lautsprechervorrichtung
JP2004144278A5 (pt)
ES1049049Y (es) Maquina cortadora de cefalopodos y otros seres vivos marinos.
NO20013730L (no) Proenergisk kosttilskudd basert på NADH, octocosanol og vitamin E

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]

Free format text: ELIMINAR ALGUMAS REIVINDICACOES

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 31/23 , A61P 1/02 , A61K 31/695 , A61K 35/78 , A61K 9/00

Ipc: A61K 31/23 (2006.01), A61P 1/02 (2006.01), A61K 31

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/09/2016, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2610 DE 12-01-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.